Focus Clinical Research

The trials here

What the 18 trials at this site are about, from their registry records.

Conditions

• Migraine3 trials
• Atopic dermatitis (eczema)2 trials
• Epilepsy2 trials
• Obesity2 trials
• Osteoarthritis2 trials
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Female infertility1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 39 trials
• Phase 28 trials

Status

• Recruiting9 trials
• Active, not recruiting5 trials
• Completed2 trials
• Enrolling by invitation1 trial
• Not yet recruiting1 trial

Lead sponsor

• Boehringer Ingelheim4 trials
• TriGemX Bio, Inc.3 trials
• Amgen2 trials
• Supernus Pharmaceuticals, Inc.2 trials
• Celldex Therapeutics1 trial
• and 6 more

Running trials

• Recruiting

  A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

  NCT07754461· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema

  NCT07765888· Phase 3· Pfizer· Source

• Recruiting

  A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07674654· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Annemarie Vance

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07645924· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Annemarie Vance

• Active, not recruiting

  A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

  NCT07662122· Phase 2· Boehringer Ingelheim· Source

• Recruiting

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· Phase 2· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea

  NCT07235917· Phase 2· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  A Study to Evaluate the Efficacy and Safey of PTP-001 (MOTYS™) in Knee Osteoarthritis Patients (MOTION-P)

  NCT07219771· Phase 3· Doron Therapeutics Inc.· Source

  Contact: Carlos Uribe

• Recruiting

  OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  NCT07136012· Phase 3· Amgen· Source

• Enrolling by invitation

  SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

  NCT07141329· Phase 2· Supernus Pharmaceuticals, Inc.· Source

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Active, not recruiting

  A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

  NCT06917404· Phase 3· Paradigm Biopharmaceuticals Ltd.· Source

• Recruiting

  A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects

  NCT06843577· Zona Health, Inc· Source

  Contact: Sagrario Garcia

• Recruiting

  RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

  NCT06798896· Phase 2· Supernus Pharmaceuticals, Inc.· Source

  Contact: Supernus Clinical Trials

• Active, not recruiting

  A Study of Barzolvolimab in Patients With Atopic Dermatitis

  NCT06727552· Phase 2· Celldex Therapeutics· Source

• Active, not recruiting

  Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

  NCT06334133· Phase 3· vTv Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy2 recruiting
• Migraine2 recruiting
• Atopic dermatitis (eczema)1 recruiting
• Coronary artery disease1 recruiting
• Female infertility1 recruiting
• High blood pressure1 recruiting
• Lupus (SLE)1 recruiting
• Osteoarthritis1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· Phase 2· Boehringer Ingelheim· Source

• Completed

  A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

  NCT06848075· Phase 2· TriGemX Bio, Inc.· Source